Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate. Article uri icon

Overview

authors

  • Tagawa, Scott T.
  • Ramaswamy, Krishnan
  • Huang, Ahong
  • Mardekian, Jack
  • Schultz, Neil M
  • Wang, Li
  • Sandin, Rickard
  • Lechpammer, Stanislav
  • George, Daniel J

publication date

  • April 1, 2022

Identity

PubMed Central ID

  • PMC9744121

Scopus Document Identifier

  • 85122896225

Digital Object Identifier (DOI)

  • 10.1038/s41391-021-00401-9

PubMed ID

  • 35039606

Additional Document Info

volume

  • 25

issue

  • 4